BioPharma Resources

Drugs by condition

Drugs approved for pneumonia

Brand-name prescription drugs and biologics whose FDA label lists pneumonia as an approved use. Matched on the label phrases: "pneumonia".

Last checked: Nov 19, 2026Source: FDA labels (openFDA), Drugs@FDAMethods & limitations

Brand-name drugs approved

57

Still marketed, NDA or BLA

Drug classes

12

Novel drugs

17

New molecular entities and new biologics

In development

15

Investigational drugs in Phase 2 or 3

Newest approvals

The most recently first-approved brand-name drugs for pneumonia.

All approved drugs for pneumonia, by class

Every marketed NDA or BLA whose current FDA label names this condition in its Indications and Usage section, plus 275 generic labels. A drug can be approved for only part of a condition (one subtype or stage, or as add-on therapy), so check its label.

Lipopeptide Antibacterial (6)

Tetracycline-class Antibacterial (4)

  • Nuzyra Omadacycline Tosylate · Paratek Pharms · 2018
  • Nuzyra Omadacycline Tosylate · Paratek Pharms · 2018
  • Tygacil Tigecycline · Pf Prism Cv · 2005
  • Tigecycline Tigecycline · Amneal · 2018

Nitroimidazole Antimicrobial (3)

Oxazolidinone Antibacterial (3)

Calculi Dissolution Agent (2)

  • Xenleta Lefamulin Acetate · Hong Kong · 2019
  • Xenleta Lefamulin Acetate · Hong Kong · 2019

Prostacycline Vasodilator (2)

  • Tyvaso Dpi Treprostinil · United Therap · 2022
  • Tyvaso Treprostinil · United Therap · 2009

Monobactam Antibacterial (1)

  • Azactam Aztreonam · Labs Delbert · 1986

Antimalarial (1)

  • Mepron Atovaquone · Glaxosmithkline LLC · 1995

Azole Antifungal (1)

Sulfonamide Antimicrobial (1)

  • Sulfatrim Sulfamethoxazole, Trimethoprim · Pharm Assoc · 1983

Macrolide (1)

  • Eryc Erythromycin · Dr Reddys Labs SA · 1981

Class not listed in FDA's data (32)

Drugs in development for pneumonia

Investigational drugs FDA has not approved, in active or recent industry-sponsored Phase 2 and 3 trials for this condition. Phase 3 first.

Search the pipeline
  • PPV2323-valent Pneumococcal Polysaccharide Vaccine, lot 1Phase 36 trials

    Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd · Healthy Volunteers, Streptococcus Pneumoniae Infection, Pneumococcal Disease

  • RaphaminMMH-407Phase 35 trials

    Materia Medica Holding · Rhinosinusitis, Rhinosinusitis Acute, Cystitis Chronic

  • PralurbactamPhase 33 trials

    Qilu Pharmaceutical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP), Complicated Intra-abdominal Infection (cIAI)

  • BV100Phase 32 trials

    BioVersys SAS · Hospital Acquired Bacterial Pneumonia (HABP), Ventilator Associated Bacterial Pneumonia (VABP), Colistin Resistanrt ABC

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • HRS-8427Phase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP), Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • nacubactamPhase 32 trials

    Meiji Seika Pharma Co., Ltd. · Complicated Urinary Tract Infection, Acute Pyelonephritis, Hospital-acquired Bacterial Pneumonia

  • YK-1169Phase 31 trial

    Nanjing Yoko Biomedical Co., Ltd. · Hospital-acquired Bacterial Pneumonia (HABP), Ventilator-associated Bacterial Pneumonia (VABP)

  • AFX3772Phase 21 trial

    GSK · Pneumonia, Bacterial, Pneumococcal Infections, Pneumonia, Pneumococcal

  • ASK0912Phase 21 trial

    Jiangsu Aosaikang Pharmaceutical Co., Ltd. · Ventilator-associated Bacterial Pneumonia (VABP), Hospital-acquired Bacterial Pneumonia (HABP)

  • AV-001Phase 21 trial

    Vasomune Therapeutics, Inc. · Acute Respiratory Distress Syndrome, Viral or Bacterial Infections, Pneumonia

  • CAL02Phase 21 trial

    Eagle Pharmaceuticals, Inc. · Pneumonia, Bacterial

  • SR1375Phase 21 trial

    Shanghai SIMR Biotechnology Co., Ltd. · Community-acquired Pneumonia

  • TQD3524Phase 21 trial

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Hospital-acquired Bacterial Pneumonia/Ventilator-associated Bacterial Pneumonia

6 discontinued brand-name drugs whose label still names it

More on pneumonia: recruiting trials · published research

Related in infectious disease and vaccines: HIV · Hepatitis B · Hepatitis C · COVID-19 · Influenza · RSV · Urinary tract infection · Skin infections · C. difficile infection · Fungal infections

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.